Biohaven Ltd. (BHVN) income statement
BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 1/30
$12.39−1.26 (-9.23%)
Close on Nov 20, 2026Market cap $1.87BP/E –Yield –
Biohaven Ltd. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -310.8%
Financial strength
- Current ratio
- 3.05
- Debt to equity
- -2.69
- Debt to assets
- 100.2%
- Cash to current liabilities
- 152.6%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?